Back to search
FDAFDA · Food and drugs·Recall number D-1094-2017

Voriconazole Tablets, 200 mg, 20-count cartons (4 x 5) Unit Dose, Rx only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 50268-804-12

Published August 23, 2017 · Recall initiated: July 19, 2017

Summary

FDA records drug Class III recall D-1094-2017, published August 23, 2017 and initiated July 19, 2017. Recalling firm: AVKARE Inc.; Status: Terminated; Reported quantity: 1172 cartons (23440 tablets); Lot: Lot #: 16933, Exp 07/2018; 17054, Exp 08/2018. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed impurities/degradation specifications: Out of specification for a related compound C.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AVKARE Inc.
Distributor
Nationwide
Lot
Lot #: 16933, Exp 07/2018; 17054, Exp 08/2018
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Voriconazole Tablets, 200 mg, 20-count cartons (4 x 5) Unit Dose, Rx only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 50268-804-12 recalled?

Yes. FDA published recall D-1094-2017 on August 23, 2017. Reported hazard: Failed impurities/degradation specifications: Out of specification for a related compound C.

What should I do if I have this product?

Voluntary: Firm initiated · Letter